focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Anyone know what the catalyst for the sell off is? Profit taking?
I'm not going anywhere, this is just a healthy retrace- only way is up for this share IMVHO
My view remains as it was a few months back- I don't think this is the time to sell CRL. Results due in coming weeks, following previous record-beating results and clear means and intention to make acquisitions. I'll not let a little dip on profit-taking spook me, rather, will be scooping up what I can.
This'll continue well past £2 this year if demand is high and more acquisitions are announced
Love this back to normality stock and so under the radar....8 posts since March. Low float. EPS, gross profit and margins all up just need to keep an eye on costs.
I have been sitting here since end of November and looking at the reopen plays benefiting.
Just watched an analyst interview - the guy on the interview was cautious about cosmetics exposure with rationale he thought the masks will still be worn so you don't need as much makeup. The woman analyst on the interview just looked at him as if he was an idiot.....make up is back irrespective of zoom calls, masks or limited return to the office.
Few chunky sells today but just profit taking me thinks- nice rise to £1 on the cards and then once more acquisition news is announced this should rocket
Just topped up here. Especially like that CRL are manufacturers and supplies of beauty products which are sold via retailers. Should serve very nicely for when lockdown ends and the consumer boom begins.
Loads of articles like this and more online:
https://www.refinery29.com/en-gb/post-lockdown-makeup-looks-trends
Good indicator that people (mainly women) can't wait to doll themselves up and go back out into the world post-pandemic... Hopefully CRL will benefit massively in this regard!
Doubled my holding here today, hoping for this to rocket come summer. Not many companies are profitable like this one atm
Well it's an extremely profitable company atm, so hopefully will see £1-2 levels fairly soon, especially once acquisitions are announced
JoeKenny- agreed a competitive sector, though must disagree with notion that CRL might have reached its limits. Rather, I'm confident that coming year will prove transformative. Record half-year results and recently made public its intentions to make acquisitions- board actively seeking to take larger slice of the sector. I'm adding on dips.
Totally agree with the increase in discretionary spending, people cant wait to go and doll themselves up with these products when the world reopens.
Though I am cautious that maybe a ceiling has been reached here? I understand that this is a very competitive market for CRL
Good case to buy and hold CRL in coming years. Motley Fool touched upon on it yesterday:
https://www.fool.co.uk/investing/2021/03/24/3-top-penny-stocks-i-might-buy-for-the-new-bull-market/
I'd not usually pay Motley Fool any mind, though in this case, in complete agreement.
Still, no time to sell in my view. CRL achieving record-beating results, SP at highs and recently shown means and intentions to make acquisitions. It looks as though 2021 may well prove a big one for CRL. Those selling- I'll gladly buy your shares!
RR_RR- Apologies for the delayed reply. The FT among others show institutional holdings where possible and though not always up to date, gives a good indication of who is in /out.
Hello,
I wondered how you get the news of institutions buying? Thanks.
Institutions appear to be buying CRL. Among them, Canaccord increased its holding in CRL by 81.87% on 2nd Feb. Little more than hunch, though wouldn't be surprised if further M&A moves to come and/or research to begin on CRL in coming months.
Troajan- many thanks for posting. CRL's bid approach for InnovaDerma a very positive indication of both ambition and healthy trading. Imagine recent bid one of a range of potential developments to come.
Fear taking hold of the wider market, it seems.
Most recent update:
Revenue +36.31%
Net Income + 60.58%
Diluted EPS + 100%
Net Profit Margin + 17.82%
Market sell-off appears irrational presenting gift to those looking beyond their noses. In my view, great opportunity in CRL at current price, as with so many others knocked down.
bobbyaxelrod- agreed, a record-beating year for CRL throughout toughest market conditions in decades. CRL's consistency over past 4-5 years not to be ignored. Sellers today might well have mistimed their exit.
42 market cap, PE 13, growing revenues and profits, growing dividend with good cover. Fantastically well-run organisation.
Adopting a Buffet approach, I ask myself would I want to own the entire business, and the answer would be a resounding yes. Took a position here earlier in the year, and expect to see consistent share price and revenue growth for the long term. The revenue drivers do not look like they will be disappearing over the next few decades.
The move into healthcare adds another revenue stream that the market isn't valuing due to these not being long term contracts. But it is unlikely that these contracts will not continue at their current levels minimum, whilst the rest of the business is growing.
Brands are doing well, global ambitions, great team, possible acquisitions (but only if they are fairly valued and add value), growing investment into digital.
Tis’ not the season to sell CRL. Record-beating update during toughest market conditions in decades. Current COVID concerns do little to change outlook here and may even bode well for CRL.
Will Simon Thompson's Blog be in this magazine tomorrow? Will he strike again? Fingers crossed!
I believe this is the case!